This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Source text - English Few cases of acute pancreatitis (inflammation of the pancreas) presenting with persistent severe abdominal pain (usually accompanied by vomiting) have been reported with liraglutide and exenatide (a drug belonging to the same drug-class as liraglutide, and currently approved for the treatment of type 2 diabetes in the US and in Europe).
Source text - English What is a stent procedure?
A stent is a small, tubular metal device that is placed in the narrow section of the artery and is intended to serve as a support to hold the arterial walls open. A stent is tightly placed on a balloon-catheter and inserted into the coronary artery. Once a stent is placed at the site of the narrowing, inflating the balloon expands the stent. After the stent has been expanded to the required diameter, the balloon is deflated and then withdrawn while the stent remains in the artery. Once a stent has been implanted, it cannot be removed.
In the recent years, drug-eluting stents have been developed to reduce the chance of a re-narrowing of the stent after implantation. Studies have demonstrated that drug-eluting stents have a lower chance of re-narrowing than a stent without a drug on it. The drug is released into the artery wall from the stent during the first months after implantation. The drug will act locally where the stent is implanted.